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Abstract
Background: Nanotechnology is a rapidly advancing industry with many new products already available to the
public. Therefore, it is essential to gain an understanding of the possible health risks associated with exposure to
nanomaterials and to identify biomarkers of exposure. In this study, we investigated the fibrogenic potential of
SWCNT synthesized by chemical vapor deposition using cobalt (Co) and molybdenum (Mo) as catalysts.
Following a single oropharyngeal aspiration of SWCNT in rats, we evaluated lung histopathology, cell
proliferation, and growth factor mRNAs at 1 and 21 days post-exposure. Comparisons were made to vehicle
alone (saline containing a biocompatible nonionic surfactant), inert carbon black (CB) nanoparticles, or vanadium
pentoxide (V2O5) as a known inducer of fibrosis.
Results: SWCNT or CB caused no overt inflammatory response at 1 or 21 days post-exposure as determined
by histopathology and evaluation of cells (>95% macrophages) in bronchoalveolar lavage (BAL) fluid. However,
SWCNT induced the formation of small, focal interstitial fibrotic lesions within the alveolar region of the lung at
21 days. A small fraction of alveolar macrophages harvested by BAL from the lungs of SWCNT-exposed rats at
21 days were bridged by unique intercellular carbon structures that extended into the cytoplasm of each
macrophage. These "carbon bridge" structures between macrophages were also observed in situ in the lungs of
SWCNT-exposed rats. No carbon bridges were observed in CB-exposed rats. SWCNT caused cell proliferation
only at sites of fibrotic lesion formation as measured by bromodeoxyuridine uptake into alveolar cells. SWCNT
increased platelet-derived growth factor (PDGF)-A, PDGF-B, and PDGF-C mRNA levels significantly at 1 day as
measured by Taqman quantitative real-time RT-PCR. At 21 days, SWCNT did not increase any mRNAs evaluated,
while V2O5 significantly increased mRNAs encoding PDGF-A, -B, and -C chains, PDGF-Rα, osteopontin (OPN),
connective tissue growth factor (CTGF), and transforming growth factor (TGF)-β1.
Conclusion: Our findings indicate that SWCNT do not cause lung inflammation and yet induce the formation of
small, focal interstital fibrotic lesioins in the alveolar region of the lungs of rats. Of greatest interest was the
discovery of unique intercellular carbon structures composed of SWCNT that bridged lung macrophages. These
"carbon bridges" offer a novel and easily identifiable biomarker of exposure.
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Background
The commercial interest in single walled carbon nano-
tubes (SWCNT) is rapidly increasing due to their superior
mechanical, electric and thermal properties [1]. With the
development of mass production and handling facilities
for SWCNT, it is critical to fully understand the risk asso-
ciated with exposure since it is likely that increasing
human exposure will occur [2]. Moreover, it would be
highly desirable to identify specific biomarkers of SWCNT
exposure in order to identify individuals who are exposed
occupationally or consumers who become exposed to
products containing SWCNT. Individual SWCNT are less
than 2 nm in diameter and form fibrous ropes that range
up to several microns in length [3]. Ropes of SWCNT fur-
ther aggregate by means of electrostatic charge to form
larger, micron-sized agglomerates.
Several recent studies indicate fibrogenic effects of
SWCNT instilled into the lungs of mice or rats. Lam et al
reported that SWCNT instilled into the lungs of mice
caused the formation of fibroproliferative lesions to the
same extent as toxic quartz particles [4]. In a similar study,
Warheit and colleagues reported that SWCNT exposure in
rats by intratracheal instillation caused pulmonary granu-
lomas, although there was a lack of lung toxicity as
assessed by lavage parameters and cell proliferation
parameters [5]. Shvedova and coworkers reported that
pharyngeal aspiration of SWCNT in mice caused progres-
sive intersitital fibrosis and granulmonas, along with
increased levels of cytokines (IL-1β and TNF-α) within 1
day and elevated TGF-β1 after 1 week [6]. All of these stud-
ies indicate that SWCNT cause some lung toxicity when
instilled or aspirated as a bolus of agglomerated nano-
ropes. Nevertheless, it remains unclear from these reports
whether SWCNT have the potential to stimulate pulmo-
nary fibrogenesis under conditions of occupational or
environmental exposure.
The overall goal of this study was to investigate changes in
the expression of genes encoding known profibrogenic
mediators in vivo following SWCNT exposure and corre-
late gene expression patterns with the formation of
fibrotic lesions in the lung. Surprisingly, no inflammation
was observed in SWCNT-exposed rats, although focal
interstitial fibrotic lesions were observed near clusters of
macrophages containing micron-sized aggregates of
SWCNT within the alveolar region of the lung. Moreover,
small but significant increases in lung mRNAs encoding
three PDGF ligands (PDGF-A, -B, -C) were observed at 1
day post-SWCNT exposure but were not elevated in the
lungs of rats exposed to carbon black (CB) nanoparticles
with a similar size and specific surface area. Interestingly,
SWCNT formed unique intercellular structures that
bridged alveolar macrophages in situ. These structures
were not observed in the lungs of CB-exposed rats. While
our results indicate relatively weak fibrogenic potential of
SWCNT in the lungs of rats, carbon bridge structures
between macrophages allowed easy identification of ani-
mals exposed to SWCNT as compared to those exposed to
CB. To our knowledge this is the first report of a biomar-
ker of carbon nanotube exposure.
Results
SWCNT stimulate the formation of focal interstitial 
fibrotic lesions in the lungs of rats
Clusters of carbon-laden macrophages were observed in
the lungs of either CB or SWCNT-exposed rats after 21
days (Fig. 1). No fibrotic lesions were observed in the
lungs of CB-exposed rats (Fig. 1C,D). Relatively small tri-
chrome-positive fibrotic lesions (~100 µm diameter) were
observed within the alveolar regions of SWCNT-exposed
rats and were adjacent to clusters of alveolar macrophages
that contained carbonaceous materials (Fig. 1E,F). These
fibrotic foci were sparsely distributed within the alveolar
region of the lung and affected less than 5% of the total
lung tissue. LDH and total protein levels measured in
BALF collected from SWCNT-exposed rats were not statis-
tically changed from controls or CB groups (data not
shown). V2O5 caused the formation of fibrotic lesions in
the alveolar region and around airways (Fig. 1G,H), con-
sistent with our previous observation of V2O5-induced
lung injury in rats [7].
Intercellular carbon structures that bridge alveolar 
macrophages are readily identifiable in cytospins of BAL 
from SWCNT exposed rats
Differential analysis of BAL cell cytospins from CB or
SWCNT-exposed rats showed no overt inflammatory
response, with greater than 95% macrophages and the
remaining 5% or less comprised of neutrophils or lym-
phocytes. A small percentage of macrophages in either the
CB or SWCNT groups contained carbon inclusions (Fig.
2). An even smaller number of BAL macrophages from the
SWCNT-exposed rats were linked by readily identifiable
carbon bridges at 21 days post-exposure. These carbon
bridges composed of SWCNT were ~5 µm in length and
possessed a unique appearance characterized by fanned
ends extending into the cytoplasm of each macrophage,
giving the overall appearance of an hourglass (Fig. 2D–F).
These structures were not apparent in BAL cytospins from
rats treated for 1 day with SWCNT. Although some macro-
phages were joined by SWCNT aggregates at day 1, these
were not the well-formed hourglass structures that were
readily identifiable at 21 days. Carbon bridges were not
observed in BAL cells isolated from CB-exposed rats (Fig.
2A–C). The results of the cytology and carbon bridge
assessment are shown in Fig. 3. There were no differences
in the total numbers of macrophages per field between CB
and SWCNT-exposed groups (Fig. 3A). In both CB and
SWCNT groups, approximately 5% of the total cells perParticle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
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Lung histopathology from rats 21 days after a single oropharyngeal aspiration exposure to saline vehicle containing 0.1%  Pluronic F-68 (A, B), carbon black ultrafine particles (C, D), aggregates of single walled carbon nanotubes, SWCNT (E, F), or  vanadium pentoxide (V2O5) (G, H). Carbon inclusions are indicated by closed arrows in panels C, D, and F Figure 1
Lung histopathology from rats 21 days after a single oropharyngeal aspiration exposure to saline vehicle containing 0.1% 
Pluronic F-68 (A, B), carbon black ultrafine particles (C, D), aggregates of single walled carbon nanotubes, SWCNT (E, F), or 
vanadium pentoxide (V2O5) (G, H). Carbon inclusions are indicated by closed arrows in panels C, D, and F. Regions of alveolar 
wall thickening in the lungs of rats exposed to SWCNT are indicated by open arrows adjacent to carbon-filled macrophages in 
panesl E and F. Original magnification 20× (panels A, C, E, G) or 40× (panels B, D, F, H).Particle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
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field contained carbon inclusions of a similar size range
(0.1 to 5 µm in diameter) (Fig. 3B). In the SWCNT groups
only, approximately one fourth of the carbon inclusions
within cells were identified as carbon bridges (Fig. 3C).
No significant differences were observed in the numbers
of mitotic figures, i.e., macrophages undergoing cell divi-
sion, between CB and SWCNT groups (Fig. 3D).
SWCNT induce cell proliferation in small granulomatous 
lesions and cause carbon bridge formation between 
macrophages in situ
The light hematoxylin counterstain used for BrdU immu-
nohistochemistry revealed a wide distribution of CB and
SWCNT aggregates possessing a similar size range of 0.5 to
5  µm in diameter within the alveolar region. A back-
ground labeling index of ~1% BrdU-positive cells were
present in the alveolar region or bronchus-associated lym-
phatic tissue (BALT) of saline vehicle-exposed control rats
(Fig. 4A,B and Fig. 5). No significant increase in BrdU
incorporation was observed in the alveolar region of CB-
exposed rats, although carbon-containing macrophages
were sparsely distributed within the alveolar region and
were observed clustered in alveolar spaces (Fig. 4C).
SWCNT-exposed rats contained BrdU-positive interstitial
cells and epithelial cells in the alveolar region and these
were limited to sparse fibroproliferative lesions (Fig. 4E).
A small number of alveolar macrophages joined by car-
bon bridges were observed in situ within the alveolar
region of SWCNT-exposed rats (Fig. 4E, inset panel).
These in situ carbon bridges between macrophages were
not observed in the lungs of CB-exposed rats. SWCNT
caused a significant increase in the BrdU labeling index at
both day 1 and day 21 (Fig. 5). SWCNT and CB caused a
slight but not statistically significant increase in lym-
phocytes within BALT at day 1 or day 21 (Fig. 4D,F and
Fig. 5). V2O5 caused a significant increase in the BrdU
labeling index in the alveolar region and particularly
within BALT at day 1 and day 21 (Fig. 4G,H and Fig. 5).
Profibrotic growth factors and procollagen gene 
expression in lungs from CB- and SWCNT-exposed rats
Quantitative real-time RT-PCR was performed on whole
lung mRNA from CB, SWCNT, and V2O5-exposed rats to
measure changes in the gene expression of a variety of
profibrotic growth factors or procollagen (COL1A2).
Platelet-derived growth factor (PDGF-A, -B, and -C)
mRNA levels were significantly increased in SWCNT-
exposed rats at day 1, although less than 2-fold over saline
controls (Fig. 6A). SWCNT also increased OPN mRNA lev-
els day 1(~5-fold) and day 21 (~2-fold) although neither
was statistically significant. V2O5  caused a significant
increase in PDGF-A, -B and -C, PDGF receptor-alpha
(PDGF-Rα), transforming growth factor-β1 (TGF-β1),
OPN, and connective tissue growth factor (CTGF) at 21
days post-exposure. Procollagen mRNAs were not
induced by either CB or SWCNT, but were decreased 5-
fold by V2O5 (Fig. 6B).
Discussion
SWCNT have been reported to cause the formation of
granulomas, a type of pulmonary fibrotic reaction in the
lung. The progression of granulomas in the lung intersti-
tium is mediated in large part by alveolar macrophages,
which accumulate at sites of particle deposition and
become activated by particle phagocytosis [8,9]. Once
activated, macrophages produce polypeptide growth fac-
tors that stimulate the proliferation of interstitial fibrob-
lasts, which are the principal collagen-producing cell that
drives fibrogenesis [10]. In the present study, we observed
small, interstitial fibrotic lesions in the lungs of rats 21
days after exposure to SWCNT. These fibroproliferative
lesions were associated with clusters of alveolar macro-
phages containing carbonaceous material. CB nanoparti-
cles of similar size and specific surface area also caused
focal clustering of macrophages with carbon inclusions
but did not induce fibrotic lesions. Our findings extend
the work of others in that we report 1) the induction of
lung mRNAs encoding PDGF ligands after SWCNT expo-
sure, and 2) the formation of intercellular carbon bridge
structures between alveolar macrophages in the lungs of
SWCNT-exposed rats.
Key growth factors that stimulate fibroblasts to proliferate
and/or migrate to sites of lung injury are PDGF [11], CTGF
[12], and OPN [13]. Other growth factors such as TNF-α
and TGF-β1 stimulate fibroblasts to deposit a collagen
matrix, which defines a fibrotic lesion [14]. We found that
SWCNT induced small but significant increases in the lev-
els of mRNAs encoding three PDGF ligands (PDGF-A, -B,
and -C) at day 1 post-exposure. SWCNT also increased
OPN mRNA levels ~5-fold at day 1 post-exposure. At 21
days after SWCNT exposure we observed slight increases
PDGF-B and OPN, whereas V2O5 induced robust and sig-
nificant increases in mRNAs encoding PDGF-A, PDGF-C,
PDGFRα, TGF-β1, OPN, and CTGF. In particular, the
induction of PDGFRα by V2O5  confirmed our earlier
observation that this growth factor receptor is up-regu-
lated in vivo during fibrogenesis [7]. In general, the induc-
tion of mRNA levels for profibrogenic factors by V2O5 21
days post-exposure correlated with the formation of dif-
fuse interstitial and airway fibrotic lesions within the lung.
Moreover, the induction of mRNAs encoding PDGFs and
OPN by SWCNT at day 1 correlated with the formation of
small, focal fibrotic lesions at day 21. In contrast, CB nan-
oparticles caused neither induction of genes nor fibrotic
lesions. The increase in mRNA encoding PDGF family
members observed at day 1 after SWCNT exposure suggest
that PDGF could play a role in the formation of SWCNT-
induced fibrotic lesions as PDGF and its receptors areParticle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
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Cytospins of bronchoalveolar lavage (BAL) cells from rats exposed to for 21 days to carbon black ultrafine particles (A–C) or  single wall carbon nanotubes, SWCNT (D–F) Figure 2
Cytospins of bronchoalveolar lavage (BAL) cells from rats exposed to for 21 days to carbon black ultrafine particles (A–C) or 
single wall carbon nanotubes, SWCNT (D–F). Carbon inclusions are indicated by arrows. Carbon bridges between macro-
phages formed only in SWCNT-exposed rats. Original magnification (40×), inset (80×).Particle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
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Quantitation of BAL cells in cytospins for assessment of carbon bridge formation between macrophages from 21  day SWCNT-exposed or carbon black (CB)-exposed rats Figure 3
Quantitation of BAL cells in cytospins for assessment of carbon bridge formation between macrophages from 21 
day SWCNT-exposed or carbon black (CB)-exposed rats. Each bar represents the mean ± SD of five animals. 
Ten fields were counted per animal and at least 500 cells per animal were counted. (A) Total cells/field, (B) 
Numbers of cells per field containing carbon inclusions, (C) Carbon bridges per field (only found in SWCNT-
exposed rats), and (D) Mitotic figures per field.Particle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
Page 7 of 13
(page number not for citation purposes)
Bromodeoxyuridine (BrdU) immunohistochemistry showing a cell proliferative responses 21 days post-exposure in the lung  alveolar region (panels A, C, E, G) and in the bronchus-associated lymphoid tissue (panels B, D, F, H) Figure 4
Bromodeoxyuridine (BrdU) immunohistochemistry showing a cell proliferative responses 21 days post-exposure in the lung 
alveolar region (panels A, C, E, G) and in the bronchus-associated lymphoid tissue (panels B, D, F, H). Saline vehicle contain-
ing 0.1% Pluronic F-68. (A, B). Carbon black treatment (C, D). SWCNT treatment (E, F). Vanadium pentoxide (V2O5) treat-
ment (G, H). Solid arrows in panels C and E indicate aggregates of carbon black and SWCNT, respectively. Inset shows two 
macrophages joined by a carbon bridge within a nearby alveolar space. Open arrows indicate representative BrdU-positive 
nuclei. Original magnification for all panels, 40×.Particle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
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Levels of growth factor and procollagen mRNAs in the lungs  of rats exposed to SWCNT, CB, or V2O5 Figure 6
Levels of growth factor and procollagen mRNAs in the lungs 
of rats exposed to SWCNT, CB, or V2O5. Whole lung RNA 
was extracted as described in Methods and mRNA expres-
sion measured by quantitative real-time RT-PCR. V2O5 was 
used as a positive control for inducing mRNA levels of profi-
brogenic mediators. (A) 1 day post-exposure. (B) 21 days 
post-exposure. Control animals were treated with vehicle 
alone (PBS with 0.1% Pluronic F-68). Data are presented as 
mean values ± SEM from three to five animals per group and 
expressed as the fold-change in mRNA relative to an 18S 
rRNA housekeeping gene. *P < 0.05 significantly increased or 
†P < 0.05 significantly decreased compared to control.
Cell proliferation at (A) day 1 and (B) day 21 post-exposure  in the lungs of mice exposed by oropharyngeal aspiration to  saline vehicle containing 0.1% Pluronic F-68, carbon black  (CB), single-walled carbon nanotubes (SWCNT) or vanadium  pentoxide (V2O5) Figure 5
Cell proliferation at (A) day 1 and (B) day 21 post-exposure 
in the lungs of mice exposed by oropharyngeal aspiration to 
saline vehicle containing 0.1% Pluronic F-68, carbon black 
(CB), single-walled carbon nanotubes (SWCNT) or vanadium 
pentoxide (V2O5). Open bars represent the labeling index in 
the alveolar region of the lung (open bars) and solid bars rep-
resent the labeling index in the bronchus-associated lym-
phatic tissue. Labelling indices were measured as described in 
Methods and are reported as the percentage of BrdU-labeled 
cells of the cells counted (minimum of 400 cells counted). *P 
< 0.05 compared to saline control.Particle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
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known to mediate fibroblast chemotaxis and proliferation
during fibrogenesis [11].
In agreement with other studies of SWCNT instillation or
pharyngeal aspiration in mice or rats, we observed inter-
stitial fibrotic lesions, albeit these lesions were relatively
small (~100 µm) and sparsely distributed. Other investi-
gators have reported more severe fibrotic or granuloma-
tous lesions within the lungs of mice or rats after SWCNT
exposure. Differences between the toxicity of SWCNT in
this study as compared to some earlier studies could be
due to differences in the delivered dose of aggregated
SWCNT or differences in the size of SWCNT aggregates
delivered to the distal lung. We aspirated 2 mg/kg SWCNT
into the lungs rats in our experiments, whereas others
have used concentrations that range from 4 to 20 mg/kg
[4,5]. Shvedova and colleagues used a dose of SWCNT
comparable to the present study and reported significant
progressive interstitial fibrosis at deposition sites of more
dispersed nanostructures [6]. While we observed most
fibrotic lesions closely adjacent to macrophage clusters
and micron-sized SWCNT aggregates, we also observed
interstitial thickening within alveolar walls characterized
by increased trichrome staining at sites distant from
SWCNT aggregates and macrophages. While our study did
not show lesions as severe as those reported by Shvedova,
there were several potentially important differences in our
materials. First, our SWCNT were synthesized by a differ-
ent method (chemical vapor deposition) and contained
different metal catalysts (cobalt and molybdenum). The
SWCNT used by Shvedova and coworkers contained trace
levels of iron catalyst. Second, while we used similar sus-
pension concentrations of SWCNT to those used by Shve-
dova et al (i.e., 2 mg/kg), based on histopathologic
evaluation it is clear that we did not achieve the same effi-
ciency of delivery. Finally, we dispersed our SWCNT with
nonionic surfactant that could have decreased the bioac-
tivity of nanoparticles. Finally, we exposed rats to SWCNT,
while Shvedova and colleagues used mice.
The dose of SWCNT used in our rodent exposures is pre-
sumably higher than would be encountered in human
exposure situations assuming that the delivered dose
reached the lung. Estimates of airborne concentration of
nanotubes material generated during handling are below
53  µg/m3 [3]. However, a limitation of oropharyngeal
aspiration and intratracheal instillation techniques is that
a bolus of particles is delivered in suspension and may not
be evenly distributed within the lung or may inadvertently
pass into the esophagus and swallowed. This could signif-
icantly reduce the predicted dose to the distal lungs. A far
superior technique to deliver nanoparticles and nano-
tubes is inhalation exposure, especially for SWCNT that
are known to have a high electrostatic potential and are
therefore predisposed to agglomeration. However, even
when aerosolizing SWCNT for inhalation exposure,
micro-sized particles are formed that will likely deposit in
the lung according to the principles of sedimentation
rather than diffusion. Nevertheless, inhalation studies will
no doubt be invaluable in addressing health effects of
nanomaterials.
A potentially important factor in determining the toxicity
of carbon nanotubes is the presence of contaminating
metals that were used as catalysts in the manufacturing
process. While much emphasis has been given to particle
size, particle shape, and increased specific surface area as
a determinant of particle toxicity, our study showed that 8
nm diameter carbon black (CB) nanoparticles (composed
entirely of elemental carbon) caused no inflammation or
fibrosis in the lungs of rats, although macrophages accu-
mulated at sites of CB deposition in the lung and engulfed
these nanoparticle aggregates. The SWCNT and CB used in
this study possessed similar specific surface areas (~300 to
600 m2/g) and yet at equivalent doses of CB and SWCNT,
only the SWCNT stimulated fibrotic responses at day 21
post-exposure. Therefore, the fibrogenic activity of
SWCNT in comparison to CB is likely due to either differ-
ences in shape or elemental composition. The SWCNT
used in this study were synthesized by chemical vapor
deposition using cobalt and molybdenum as catalysts.
While the raw nanotubes formed by this process are sub-
sequently acid washed to remove contaminating metal
catalysts, residual cobalt and molybdenum remained as
2.6% and 1.7% of the total elemental composition,
respectively. Individuals exposed to occupationally to
cobalt are at risk of developing "hard metal disease",
which includes the formation of interstitial pulmonary
fibrotic lesions [15]. Other reports of SWCNT-induced
interstitial fibrosis have used materials synthesized by
laser ablation or a high-pressure carbon monoxide dispro-
portionation (HiPCO) process, both of which require
metal catalysts [4-6]. Warheit and colleagues used SWCNT
synthesized by laser ablation that contained 5% nickel
and 5% molybdenum, while studies by Shvedova et al
and Lam et al used SWCNT synthesized by HiPCO that
contained residual iron concentrations of 0.23% and
2.14%, respectively. Iron has been proposed to mediate
the toxic effects of air pollution particles and asbestos fib-
ers by generating reactive oxygen species through the Fen-
ton reaction [15,16]. Moreover, loading nonfibrogenic
titanium dioxide particles with iron has been shown to
make these particles fibrogenic in a rat tracheal explant
model [17]. Therefore, metals such as cobalt and iron
likely contribute to the surface reactivity of SWCNT. This
is supported by our observation that CB nanoparticles,
which possessed the same surface area as SWCNT and yet
did not contain contaminating metals, caused no fibrotic
effects in the lungs of rats. Warheit and colleagues recently
reported that various quartz particles produced differen-Particle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
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tial degrees of pulmonary toxicity correlated with surface
activity rather than particle size [18]. We further propose
that low levels of contaminating metals coupled with high
surface area determine the toxicity and fibrogenic poten-
tial of SWCNT.
We discovered unique carbon structures formed of
SWCNT that bridged a small percent of alveolar macro-
phages within the lung. Approximately 5% of alveolar
macrophages collected by BAL contained carbon inclu-
sions after exposure to either CB or SWCNT. Approxi-
mately one fourth of the macrophages with carbon
inclusions in the SWCNT-exposed rats were joined by car-
bon bridges at 21 days post-exposure. The unique hour-
glass structure of carbon bridges that joined macrophages
were not readily apparent in BAL cytospins at day 1 post-
SWCNT exposure, although some groups of macrophages
were clustered around SWCNT aggregates thereby indicat-
ing the early stages of bridge formation. Carbon bridges
were not observed in any CB-exposed rats despite similar
numbers of lung macrophages that engulfed carbon
aggregates composed of either CB and SWCNT in a com-
parable size range of 0.5 to 3 µm. The appearance of
micron-sized carbon bridges between macrophages at 21
days was so reliable that we were able to correctly identify
all SWCNT-exposed rats by evaluating the BAL cytospins
using light microscopy in a blinded analysis. These struc-
tures may have important future implications for deter-
mining human exposure to SWCNT.
How carbon bridges form in the lung after SWCNT is not
entirely clear. Preliminary observations with NR8383
macrophages indicate that some bridges form during
cytokinesis with the resulting daughter cells joined by
aggregated bundles of SWCNT (Mangum and Bonner,
unpublished observation). We did not detect carbon
bridges between macrophages in situ in the lungs of rats or
in BAL cytospins 1 day after SWCNT exposure. This obser-
vation suggests that phagocytosis by two or more macro-
phages is an unlikely mechanism of bridge formation. In
addition, bridge formation is not akin to "frustrated" or
incomplete phagocytosis of long (>17 µm) asbestos or
man-made fibers, where macrophages viewed in real time
avidly move along the length of the fiber [19]. Further-
more, the biological or functional consequence of carbon
bridge formation has yet to be determined. Carbon
bridges could affect the phagocytic function of macro-
phages or inhibit their ability to release or respond to
cytokines. While potentially important, these issues could
be difficult to address as only about one percent of alveo-
lar macrophages within the lung at 21 days post-exposure
were linked by carbon bridges. Because of the low percent-
age of macrophages linked by carbon bridges, it is also not
likely that these structures would have a deleterious effect
on the overall lung macrophage population.
Conclusion
Despite similar size and specific surface area of carbon
black nanoparticles and SWCNT used in this study, only
SWCNT caused 1) interstitial fibrotic lesions in the lungs
of rats, 2) significant increases in lung PDGF mRNA levels,
and 3) formation of unique carbon bridge structures
between alveolar macrophages in situ. These differences
between carbon black nanoparticles and SWCNT suggest
that the fibrogenic activity of SWCNT is due to factors that
make them unique from carbon black nanoparticles,
including their unique shape or the presence of contami-
nating metal catalysts used in the manufacturing process.
Finally, carbon bridge structures that form between mac-
rophages are likely due to unique structural characteristics
of SWCNT. Intercellular carbon bridge structures that link
macrophages serve as a useful biomarker of SWCNT expo-
sure in macrophages retrieved by bronchoalveolar lavage.
Methods
Animals
Six-week old female pathogen-free CDF (F344)/CrlBR rats
were purchased from Charles River Breeding Laboratories,
Kingston, NY, and housed in an International Association
for Assessment and Accreditation of Laboratory Animal
Care (AAALAC)-accredited humidity and temperature
controlled facility. Rats were housed in microisolator
cages on Alpha-dri cellulose bedding and supplied water
and cereal-based diet NIH07 (Zeiger Brothers., Gardners,
PA) ad libitum. The animal studies were approved by the
CIIT Centers for Health Research Institutional Animal
Care and Use Committee.
General experimental design
The objective of this study was to determine whether
SWCNT are fibrogenic in the lungs of rats after exposure
by oropharygneal aspiration. Moreover, we sought to
determine whether SWCNT increase mRNA levels of
growth factors that mediate a fibrogenic response. We
hypothesized that SWCNT would increase the expression
of pro-fibrotic growth factors (PDGF, CTGF, TGF-β1) and
thereby induce interstitial fibrosis. Oropharyngeal aspira-
tion is a standard method for delivering particle suspen-
sions to the lung and results in better particle distribution
throughout the lung as compared to intratracheal instilla-
tion. Quantitative real time RT-PCR is the optimal
method for measuring changes in growth factor mRNA
levels in the lungs of exposed animals and changes in
mRNA can be normalized for several standard housekeep-
ing genes (described below under Taqman quantitative real
time RT-PCR). Animals were acclimated for two weeks and
then randomly assigned into treatment groups according
to body weight prior to particle exposure. Rats were
exposed to 2 mg/kg of SWCNT by oropharyngeal aspira-
tion. Negative control animals were treated with Ca2+ and
Mg2+ -free phosphate-buffered saline (PBS) with 0.1%Particle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
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pluronic. Carbon black (CB) particles were used as a neg-
ative control particle that does not cause fibrosis. Vana-
dium pentoxide (V2O5) was used as a positive control for
causing a fibrotic response in the lungs of rats. Animals
were killed by pentobarbitol overdose at 1 and 21 days
following particle exposure. The lungs were lavaged with
PBS. The left lungs were used to assess lung cell prolifera-
tion and histopathology. The right lung lobes were snap-
frozen in liquid nitrogen stored at -80°C until used for
RNA isolation and assessment of gene expression by real
time quantitative RT-PCR.
Particles
High-purity SWCNT were purchased from Helix Material
Solutions, Richardson, TX [19]. These SWCNT were pro-
duced by a chemical vapor deposition process yielding
particle external diameters of less than 2 nm with lengths
ranging from 0.5 to 40 microns and a purity > 90% as
determined by transmission electron microscopy (TEM),
scanning electron microscopy (SEM), Raman spectros-
copy and thermogravimetric analysis (TGA). SWCNT con-
tained less than 5% amorphous carbon. The specific
surface area of SWCNT was 300–600 m2/g. The elemental
composition of SWCNT as determined by energy disper-
sive X-ray diffraction was 89.6% carbon, 6.1% oxygen,
2.6% cobalt (Co), and 1.7% molybdenum (Mo). Co and
Mo were metal catalysts used in the chemical vapor depo-
sition process. Nanosized CB particles (Raven 5000 Ultra
II) were obtained from Columbian Chemicals Company,
Marietta, GA [20]. The Raven 5000 Ultra II CB had a mean
particle size of 8 nm and specific surface area between
350–583 m2/g. Vanadium pentoxide V2O5, (also referred
to as vanadium oxide V) was obtained from Sigma-
Aldrich, (St. Louis, MO). V2O5 was used as a positive
profibrogenic agent and was purchased as an 8 micron
mesh size (i.e., particles <8 micron). However, V2O5 is at
least partly soluble in aqueous solutions and was there-
fore not compared on a size basis to CB and SWCNT. Dry
CB and SWCNT were milled in a Retsch Mixer Mill (Retsch
Inc., Newtown, PA) for 5 minutes at 30 cycles per second.
The milled nanoparticles were then suspended in a bio-
compatible nonionic surfactant, 1% Pluronic F-68 (BASF
Corp., Florham Park, NJ) in PBS and wet milled for an
additional 5 min. The CB and SWCNT suspensions were
further diluted with PBS to achieve the desired final dos-
ing concentration of 0.1% Pluronic F-68. V2O5 particles
were suspended in PBS with 1% Pluronic F-68, sonicated
for 30 minutes, then further diluted 1:10 with PBS. Lastly,
all particles were kept dispersed by placing suspensions in
an ultrasonic waterbath until vortex mixed just prior to
instillation. All particles were sterilized prior to instilla-
tion.
Instillation of nanoparticles
Rats were administered particles by oropharyngeal aspira-
tion. In brief, animals were anesthetized with isofluorane
and ~100 µl volume of either CB, SWCNT or V2O5 (dose
concentration equivalent of 2 mg of particles per kg of
bodyweight) was placed at the back of the throat while
holding the rat's tongue until the suspension was aspi-
rated into the lungs. Control rats were administered an
equivalent volume of PBS with 0.1% Pluronic F-68 sur-
factant.
Bronchoalveolar Lavage
Rats were euthanized by pentobartital overdose and lungs
were lavaged five times with 5-ml volumes of PBS. Two
bronchoalveolar lavage (BAL) samples representing the
first two and subsequent three recovered lavages were
pooled and placed on ice. We established that this gentle
lavage procedure does not compromise lung architecture
as compared to animals that were not lavaged nor does it
induce mRNA levels encoding pro-inflammatory
cytokines or pro-fibrotic growth factors. BAL cells col-
lected by centrifugation were resuspended in culture
medium and enumerated using an automated cell counter
(Model ZM, Coulter, Marietta, GA). Cytospins were pre-
pared with approximately 105 cells per slide. Cell differen-
tial counts were performed on HEMA-3 (Fisher Scientific,
Pittsburgh, PA) stained cytocentrifuge slide preparations.
Total protein and LDH in cell-free BALF from the first two
pooled lavages were analyzed spectrophotometrically
using a COBAS FARA II (Roche Diagnostic Systems Inc.,
Montclair, NJ).
Lung histopathology and cell proliferation
One hour prior to euthanasia, rats received a single intra-
peritoneal injection of 50 mg/kg body weight of bromo-
deoxyuridine (BrdU; Sigma-Aldrich). At necropsy, left
lungs were pressure-infused intratracheally (30 cm H2O)
with 10% neutral-buffered formalin. Lungs were fixed for
approximately 48 h and then changed to 70% ethanol.
Subsequently, the lungs were embedded in paraffin, sec-
tioned at 5 µm, and stained with Masson's trichrome or
immunostained for bromodeoxyuridine (BrdU) by estab-
lished methods [22]. Cell labeling indices were deter-
mined in the bronchiolar/alveolar region and in the
bronchus-associated lymphoid tissue for each animal,
and the mean labeling index was calculated for each
group of five animals.
Cytology and carbon bridge assessment
In order to validate our observations in a quantitative,
unbiased manner, BAL cell cytospin slides were scored in
a blinded fashion; i.e., without knowing which cytospins
were from CB or SWCNT exposure groups. Cell numbers
were quantified by light microscopy using the 40× objec-
tive and a squared grid eyepiece graticule (field area =Particle and Fibre Toxicology 2006, 3:15 http://www.particleandfibretoxicology.com/content/3/1/15
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0.173 mm2). Ten microscopic fields were counted per ani-
mal and at least 500 cells per animal were counted. Four
parameters were measured; A) Total cells/field, B) Num-
bers of cells per field containing carbon inclusions, C)
Carbon bridges between macrophages per field, and D)
Mitotic figures per field.
Taqman quantitative real time RT-PCR
Total RNA from right anterior lungs of particle-treated rats
was isolated using TRIZOL reagent (Invitrogen, Carlsbad,
CA), followed by RNA cleanup performed using RNeasy
Midi spin columns (Qiagen, Valencia, CA). One or two
micrograms of total RNA was reverse transcribed at 48°C
for 30 minutes using Moloney murine leukemia virus
reverse transcriptase (Eurogentec, San Diego, CA) in 1 ×
RT buffer, 5 mM MgCl2, 500 µM of each dNTP, 2.5 µM of
random nonamers, and 0.4 U/µL RNase inhibitor in a vol-
ume of 100 µl. Twenty nanograms of the RT product was
amplified using Taqman Gene Expression Assays specific
for platelet-derived growth factor receptor alpha (PDG-
FRα), PDGF-A, PDGF-B, PDGF-C, transforming growth
factor beta-1 (TGF-β1), osteopontin (OPN), connective
tissue growth factor (CTGF), Type I procollagen
(COL1A2), and 18S on the Applied Biosystems 7900
Prism® Sequence Detection System (Applied Biosytems,
Foster City, CA). The PCR conditions and data analysis
were performed according to the manufacturer's protocol
described in User bulletin no.2, Applied Biosystems Prism
7700 Sequence Detection System. Gene expression was
measured by the quantitation of cDNA converted from
mRNA corresponding to the target genes relative to the
vehicle-treated control groups and normalized to eukary-
otic 18S reference endogenous control. Relative quantita-
tion values (2-∆∆CT) were expressed as fold-change over
controls.
Statistical methods
All data were tested for normality and homogeneity of
variance. Gene expression data were log transformed and
comparisons to controls were made using Dunett's test (P
< 0.05). The software package JMP (SAS Institute, Cary,
NC) was used for the statistical analysis.
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